Cellectar Biosciences, Inc.
CLRB
$4.76
$0.061.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -57.32% | -65.26% | 143.48% | 80.46% | 402.02% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.58% | -26.15% | 8.28% | 45.60% | 345.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -54.78% | -64.00% | 131.99% | 78.52% | 397.45% |
|
|
|||||
| Total Current Assets | -54.78% | -64.00% | 131.99% | 78.52% | 397.45% |
| Net Property, Plant & Equipment | -27.71% | -25.86% | -25.03% | -3.32% | 66.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -53.39% | -62.61% | 110.95% | 73.05% | 351.43% |
|
|
|||||
| Total Accounts Payable | -27.61% | -47.60% | -55.27% | 6.27% | 1.12% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.02% | 19.05% | 43.05% | 43.52% | 44.22% |
| Total Finance Division Other Current Liabilities | -87.30% | -90.24% | -89.34% | 38.71% | -- |
| Total Other Current Liabilities | -87.30% | -90.24% | -89.34% | 38.71% | -- |
| Total Current Liabilities | -61.32% | -78.91% | -62.98% | 23.34% | 135.34% |
|
|
|||||
| Total Current Liabilities | -61.32% | -78.91% | -62.98% | 23.34% | 135.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.29% | -18.57% | -17.09% | -15.78% | -14.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -60.13% | -77.93% | -62.10% | 22.15% | 123.93% |
|
|
|||||
| Common Stock & APIC | 12.82% | 16.39% | 42.75% | 26.24% | 20.78% |
| Retained Earnings | -12.62% | -10.70% | -21.99% | -16.64% | -17.33% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.63% | 269.33% | 169.44% | 110.52% | 345.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -79.37% | -89.69% | -68.60% | -22.30% | 567.55% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -79.37% | -89.69% | -68.60% | -22.30% | 567.55% |
|
|
|||||
| Total Common Equity | 22.63% | 269.33% | 169.44% | 110.52% | 345.40% |
| Total Preferred Equity | -79.37% | -89.69% | -68.60% | -22.30% | 567.55% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.75% | -30.60% | 213.79% | 262.30% | 3,047.11% |
|
|
|||||